Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 08, 2017

Dicerna Pharmaceuticals, Inc. v. Alnylam Pharmaceuticals, Inc.

Track this case

Case Number:

1:17-cv-11466

Court:

Massachusetts

Nature of Suit:

Anti-Trust

Judge:

Nathaniel M. Gorton

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 20, 2018

    Alnylam, Dicerna Settle Trade Secrets Case Ahead Of Trial

    With a trial looming, Dicerna Pharmaceuticals Inc. announced Friday it would shell out $15 million and close to a million shares of common stock to end Massachusetts state and federal court litigation with Alnylam Pharmaceuticals Inc. in which both sides accused the other of misappropriating trade secrets for technology related to RNA interference.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login